Triple-S Management $900 million acquisition by GuideWell
We are advising Triple-S on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
New Frontier Health going-private transaction
We are advising the special committee of the board of New Frontier Health in connection with its going-private acquisition
Colfax $287.3 million secondary offering
We advised certain selling stockholders on the transaction
Novo Nordisk acquisition of Neotope Neuroscience
We advised Novo Nordisk on the acquisition
Novo Holdings investment in Availity
We advised Availity on the investment
Mathys sale to DJO
We are advising the Mathys family on the sale
Esco Lifesciences $200 million Series A financing
We are advising Esco Lifesciences on its Series A financing
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
Evernorth acquisition of MDLIVE
We are advising MDLIVE on the transaction